Creating Acetaminophen from Plastic Waste
Researchers at the University of Edinburgh have developed a method to convert specific plastic garbage into acetaminophen, utilizing the intrinsic properties of the common bacterium E. coli. This advancement marks a significant breakthrough, potentially paving the way for more sustainable pharmaceutical production while simultaneously tackling global plastic waste challenges.
Under the leadership of Stephen Wallace, the research discovered that E. coli cells naturally contain phosphate, an organic substance capable of inducing a chemical transformation referred to as the Lossen rearrangement. Essentially, this involves the restructuring of atoms in a hydroxamate ester to yield isocyanate. This intermediary compound can react with water to generate primary amines, crucial components in various biological functions and the creation of pharmaceuticals.
Innovative Approach Using Synthetic Biology
Through state-of-the-art synthetic biology, the researchers manipulated these bacteria's cellular processes to convert terephthalic acid—a byproduct of PET—into acetaminophen's active ingredient. A fermentation technique, reminiscent of beer brewing, was employed to expedite this conversion of plastic waste into the drug within a mere 24-hour timeframe, achieving a 90 percent production rate of acetaminophen in the end product.
A notable aspect of this method is its environmentally friendly nature, operating at ambient temperatures with negligible carbon emissions, suggesting an eco-friendly avenue for drug manufacture.
Wallace expressed surprise at the natural occurrence of the Lossen rearrangement within living bacteria without requiring additional catalysts. The bacteria inherently possessed the necessary mechanisms for the reaction, requiring only guidance for the desired outcome. 'We utilized synthetic biology to engineer novel pathways inside bacteria, directing their natural chemistry to synthesize the drug,' Wallace elaborated.
Toward a Greener Pharmaceutical Industry
Although the study, showcased in a scientific journal, stands as a pioneering instance of producing acetaminophen from plastic waste via bacterial processes, further investigation is essential for scaling up to industrial production. Safety evaluations for human consumption are also required, signaling the need for ongoing research.
While continuing studies are necessary, the findings suggest promising pathways for reducing plastic waste and lowering greenhouse emissions linked to the pharmaceutical sector. The conventional production of medications like acetaminophen heavily relies on fossil fuels, majorly contributing to climate issues. Concurrently, PET generates over 350 million tons of waste annually, detrimentally impacting ecosystems.
Highlighting the potential of this innovation, Wallace concluded, 'This research demonstrates that PET plastic can be more than just disposable waste—microorganisms can transform it into valuable products, including those with medicinal potential.'



Leave a Reply